v3.26.1
STOCKHOLDERS’ DEFICIT
3 Months Ended
Jun. 30, 2026
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE – 8 STOCKHOLDERS’ DEFICIT

 

The Company is authorized to issue two classes of capital stock, up to 36,100,000,000 shares.

 

Preferred Stock

 

The Company is authorized to issue 100,000,000 shares of preferred stock, with a par value of $0.0001. The Company has one class of Preferred Stock designated with 50,000,000 shares authorized as Series C Preferred Stock, with a par value of $0.001 per share. Each one share of Series C Convertible Preferred Stock converts into 100 shares of common stock of the Company at the election of the holder, subject to equitable adjustments.

 

As of June 30, 2026 and March 31, 2026, the Company had 30,000,000 shares of Series C Preferred Stock issued and outstanding.

 

Common Stock

 

The Company is authorized to issue 36,000,000,000 shares of common stock, with a par value of $0.0001 per share.

 

As of June 30, 2026 and March 31, 2026, the Company had a total of 10,881,149 and 10,881,149 shares of its common stock issued and outstanding, respectively.

 

Deferred compensation

 

On July 15, 2025 and December 16, 2025, the Company issued 1,333,333 and 8,000,000 shares of its common stock to settle the consulting and service fee to consultants who provided the marketing campaign and develop new business services to the Company, respectively.

 

At June 30, 2026 and March 31, 2026, the Company’s share issued for services rendered was $0 and $4,878,400, respectively, which is recorded in deferred compensation in the accompanying unaudited condensed consolidated balance sheets.

 

The Company recognized the amortization of deferred compensation $854,700 and $0 for the three months ended June 30, 2026 and 2025.